Alisertib
Drug timelines are a Plus or Pro feature.
43 regulatory and trial events tracked for Alisertib, covering 2013-11-01 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma [Phase 1]